Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1987 May-Jun;2(3):141-8.
doi: 10.1007/BF02596140.

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing

Clinical Trial

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing

R H White et al. J Gen Intern Med. 1987 May-Jun.

Abstract

In a prospective, randomized study at two university hospitals, the authors examined how effectively housestaff physicians (n = 36) managed the initiation of warfarin therapy compared with a computer-assisted dosing regimen (n = 39) using the software program Warfcalc, which was managed by one of the authors. Target prothrombin time ratios were selected by the physicians. Study endpoints included: the time to reach a therapeutic prothrombin ratio, the time to reach a stable therapeutic dose, the number of patients transiently overanticoagulated, the number of bleeding complications, and the accuracy of the predicted maintenance dose, which was assessed at steady-state 10-14 days later. Computer-assisted dosing consistently out-performed the physicians: a stable therapeutic dose was achieved 3.7 days earlier (p = 0.002), fewer patients were overanticoagulated (10% versus 41%), and the predicted maintenance dose was in the therapeutic range in 85% of the computer-dosed patients versus 42% of the physician group (p less than 0.002). For physicians who did not routinely manage warfarin therapy, computer-assisted dosing improved the accuracy of dosing and shortened the time required to achieve a stable therapeutic dose.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharm. 1985 Jul-Aug;4(4):440-6 - PubMed
    1. Ther Drug Monit. 1985;7(2):174-80 - PubMed
    1. Semin Hematol. 1980 Oct;17 (4):259-91 - PubMed
    1. N Engl J Med. 1982 Dec 30;307(27):1676-81 - PubMed
    1. Br Med J (Clin Res Ed). 1984 Apr 28;288(6426):1268-70 - PubMed

LinkOut - more resources